<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02610608</url>
  </required_header>
  <id_info>
    <org_study_id>AMPERT (RB13.160)</org_study_id>
    <nct_id>NCT02610608</nct_id>
  </id_info>
  <brief_title>Medical Assistance for the Procreation and Risk of Thrombosis.</brief_title>
  <acronym>AMPERT</acronym>
  <official_title>Assistance Médicale à la Procréation et Risque Thrombotique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at evaluating clincal practice regarding prevention of arterial and venous
      thrombosis following ovarian stimulation.

      Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous
      thrombosis in women undergoing assisted reproductive technology and 2)to identify the
      incidence and risk factors for ovarian hyperstimulation syndrome in these women
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All women undergoing an assisted reproductive tecnology in order to receive an in vitro
      fertilization in French centers will be included in the study. These women will be followed
      up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the
      stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian
      hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked
      whether arterial and/or venous thrombosis had occured.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    RECRUITMENT DIFFICULTIES
  </why_stopped>
  <start_date type="Actual">February 2, 2016</start_date>
  <completion_date type="Actual">November 20, 2016</completion_date>
  <primary_completion_date type="Actual">November 20, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of professional clinical practice for ovarian stimulation care</measure>
    <time_frame>Until 12 months followin ovarian stimulation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial and/or venous thrombosis</measure>
    <time_frame>until 12 months following ovarian stimulation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors for thrombosis</measure>
    <time_frame>until 12 months following ovarian stimulation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence and risk factors for ovarian hyperstimuation syndrome</measure>
    <time_frame>until 12 months following ovarian stimulation</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">129</enrollment>
  <condition>Ovarian Hyperstimulation Syndrome</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Embolism and Thrombosis</condition>
  <arm_group>
    <arm_group_label>Women undergoing ART</arm_group_label>
    <description>Observation of the incidence of venous and arterial thrombosis following ovarian stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ovarian stimulation</intervention_name>
    <description>evaluation of clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation</description>
    <arm_group_label>Women undergoing ART</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      One blood sample for each women particpating in the study
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing assisted reproductive thechnology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All women undergoing ovarian stimulation in order to receive in vitro fertilization

        Exclusion Criteria:

          -  Age&lt;18 years

          -  Women refusing to particpate in the study

          -  No health coverage

          -  Women under guardianship

          -  Women receiving therapeutic doses of anticoagulation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medicentre- Clinique du Val d'Ouest</name>
      <address>
        <city>Ecully</city>
        <zip>69130</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SELARL Gynecologia</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Joseph</name>
      <address>
        <city>Marseille</city>
        <zip>13001</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpital de l'Archet</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hôpital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Multualiste La sagesse</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Mathilde</name>
      <address>
        <city>Rouen</city>
        <zip>76100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg - CMCO</name>
      <address>
        <city>Schiltigheine</city>
        <zip>67300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Embolism and Thrombosis</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

